The cost-effectiveness of treatment in chronic HBV non-cirrhotic hepatitis – finite versus long-life therapy

[摘要]

[发布日期] 2014-10-15 [发布机构]

[效力级别] [学科分类]

[关键词] Entecavir;HBsAg Loss;Good Therapeutic Strategy;Cost Simulation;Real Life Study [时效性]

浏览次数：5